Bohnhoff James C, Cutler Anya, Price Julia, Ahrens Katherine, Gabrielson Sarah M B, Hathaway Warren, Miller Thomas A
Department of Pediatrics, MaineHealth, Portland, ME, USA.
Center for Interdisciplinary Population and Health Research, MaineHealth Institute for Research, Portland, ME, USA.
Cardiol Young. 2025 Jan;35(1):183-191. doi: 10.1017/S1047951124036321. Epub 2024 Dec 6.
In North America, less than 30% of children with complex CHD receive recommended follow-up for neurodevelopmental and psychosocial care. While rates of follow-up care at surgical centres have been described, little is known about similar services outside of surgical centres.
This cohort study used Maine Health Data Organization's All Payer Claims Data from 2015 to 2019 to identify developmental and psychosocial-related encounters received by children 0-18 years of age with complex CHD. Encounters were classified as developmental, psychological, and neuropsychological testing, mental health assessment interventions, and health and behaviour assessments and interventions. We analysed the association of demographic and clinical characteristics of children and the receipt of any encounter.
Of 799 unique children with complex CHD (57% male, 56% Medicaid, and 64% rural), 185 (23%) had at least one developmental or psychosocial encounter. Only 13 children (1.6%) received such care at a surgical centre. Developmental testing took place at a mix of community clinics/private practices (39%), state-based programmes (31%), and hospital-affiliated clinics (28%) with most encounters billing Medicaid (86%). Health and behavioural assessments occurred exclusively at hospital-affiliated clinics, predominately with Medicaid claims (82%). Encounters for mental health interventions, however, occurred in mostly community clinics/private practices (80%) with the majority of encounters billing commercial insurance (64%).
Children with complex CHD in Maine access developmental and psychosocial services in locations beyond surgical centres. To better support the neurodevelopmental outcomes of their patients, CHD centres should build partnerships with these external providers.
在北美,患有复杂性先天性心脏病(CHD)的儿童中,接受推荐的神经发育和心理社会护理随访的比例不到30%。虽然已经描述了手术中心的随访护理率,但对于手术中心以外的类似服务却知之甚少。
这项队列研究使用了缅因州健康数据组织2015年至2019年的所有支付方索赔数据,以确定0至18岁患有复杂性CHD的儿童接受的与发育和心理社会相关的诊疗。诊疗被分类为发育、心理和神经心理测试、心理健康评估干预以及健康和行为评估与干预。我们分析了儿童的人口统计学和临床特征与接受任何诊疗之间的关联。
在799名患有复杂性CHD的独特儿童中(57%为男性,56%为医疗补助参保者,64%为农村居民),185名(23%)至少有一次发育或心理社会诊疗。只有13名儿童(1.6%)在手术中心接受此类护理。发育测试在社区诊所/私人诊所(39%)、州级项目(31%)和医院附属诊所(28%)进行,大多数诊疗由医疗补助付费(86%)。健康和行为评估仅在医院附属诊所进行,主要是医疗补助索赔(82%)。然而,心理健康干预诊疗大多发生在社区诊所/私人诊所(80%),大多数诊疗由商业保险付费(64%)。
缅因州患有复杂性CHD的儿童在手术中心以外的地方获得发育和心理社会服务。为了更好地支持患者的神经发育结果,CHD中心应与这些外部提供者建立伙伴关系。